KFDA approved product licence transfer to Green Cross affiliates

Published: 1999-07-26 14:17:00

Updated: 1999-07-26 14:17:00

The transfer of individual product licence permitted for the company M&A and split made it possible that the local pharmaceutical industry could enhance international competitiveness by a massive restructuring for industrial specialization and an activation of venture enterprises.

The KFDA app...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK